Following the implementation of the new critical illness (CI) definitions in April, the IFA market has called for positive retrospective CI changes to be made to existing policies. What do you think about such an idea? What are the pros and cons?
Market viewsRoger Edwards, Bright GreyMy initial reaction to a question like this is always to think about what is right for the customer. At a high level, it seems logical to "upgrade" existing policies to include extra illnesses - especially if the new ones are rare conditions where the added risk cost is low. But this may set the wrong precedent if, at a later date, the provider adds in a new condition where the risk cost is very high - perhaps a newly identified and serious illness, like HIV was in the 1980s. Or if the provider wants to increase the level of critical illness (CI) cover....
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes





